Supreme Court Flags Excess Records as Cause of Delays in Corruption Case Prosecutions || Supreme Court: Outgoing Partner’s Share Valued on Assessment Date, Not Dissolution Date || Supreme Court Acquits Two Murder Convicts, Finds Prosecution Story Suspicious || SC Restores SEBI Fraud Proceedings against Vedanta over 2014 Share Buyback || CCI Rejects Kerala Private Bus Operators’ Challenge to Free KSRTC Travel for Women || Chhattisgarh HC: Sharia Body can't Decide Muslim Woman's Marital Status or End Marriage || MP High Court: Adult Woman Can Become Jain Saadhvi Despite Parents’ Opposition || MP High Court Quashes 70%-80%-90% Pay Rule for Class III, IV Staff during Probation || SC: Pre-2015 NH Act Awards Must Follow 1894 Act for Solatium and Interest || SC: Service Rendered Before Regularization Must Be Counted for Pension Benefits

Delhi HC Issues Notice in PIL Seeking Selling of Remdesivir by All Pharma Firms in Domestic Market - (04 May 2021)

CIVIL

Delhi High Court has issued notice to the Centre and various pharma majors asking them to respond to a Public Interest Litigation seeking that all drug firms involved in the making Remdesivir be allowed to sell it in the domestic market. The Court has issued the notice to the Health Ministry, Central Drugs Standard Control Organisation, Director General of Foreign Trade, and various pharma companies, like Cipla, Zydus, and Cadila, seeking their stand on the issue.

Tags : DELHI HIGH COURT SELLING OF REMDESIVIR

Share :